Bernard Pécoul
Director/Board Member at Medicines Patent Pool Foundation
Profile
Bernard Pécoul is a Member-Governance Board at Medicines Patent Pool Foundation since 2015.
Prior to this, he was the Executive Director at Drugs for Neglected Diseases initiative from 2003 to 2022 and Campaign Director at Medecins Sans Frontières (UK) from 1998 to 2003.
He holds a graduate degree from Tulane University (Louisiana) and a doctorate degree from Université Blaise Pascal.
Bernard Pécoul active positions
Companies | Position | Start |
---|---|---|
Medicines Patent Pool Foundation | Director/Board Member | 27/10/2015 |
Former positions of Bernard Pécoul
Companies | Position | End |
---|---|---|
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Director/Board Member | 05/09/2022 |
Medecins Sans Frontières (UK)
Medecins Sans Frontières (UK) Services to the Health IndustryHealth Services Médecins Sans Frontières (UK) is a non-profit organization that was founded in 1971. The non-profit company is based in London, UK. MSF provides vital medical care to people in over 65 countries who are affected by wars, natural disasters, and epidemics. The British company offers affordable access to high-quality education in tropical medicine through a part-time course. MSF relies on private individuals and organizations for 100% of their donations, and their network of fundraisers helps them deliver life-saving care across the world. The company's commitment to offering high-quality medical care in challenging settings has made research and innovation a part of their lifeblood. | Corporate Officer/Principal | 01/01/2003 |
Training of Bernard Pécoul
Tulane University (Louisiana) | Graduate Degree |
Université Blaise Pascal | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Health Technology |
Medecins Sans Frontières (UK)
Medecins Sans Frontières (UK) Services to the Health IndustryHealth Services Médecins Sans Frontières (UK) is a non-profit organization that was founded in 1971. The non-profit company is based in London, UK. MSF provides vital medical care to people in over 65 countries who are affected by wars, natural disasters, and epidemics. The British company offers affordable access to high-quality education in tropical medicine through a part-time course. MSF relies on private individuals and organizations for 100% of their donations, and their network of fundraisers helps them deliver life-saving care across the world. The company's commitment to offering high-quality medical care in challenging settings has made research and innovation a part of their lifeblood. | Health Services |
Medicines Patent Pool Foundation |
- Stock Market
- Insiders
- Bernard Pécoul